1st Phorm International LLC
Classification
Private
Financials
Revenue & Profit
Valuation
Ratios
People
Deals
M&A2024-03-15Completed
Investor Sponsors NorthBridge PE | Stake Tags 100% |
Deal Amount $120M | Is PE deal Yes |
Target Company Valuation $1.20 MM | Is deal PE backed Yes |
Techniques Acquisition of Assets, Taken Private | Total Acquired 100% |
Investor Sponsors
Deal Amount
$120M
Target Company Valuation
$1.20 MM
Techniques
Acquisition of Assets, Taken Private
Stake Tags
100%
Is PE deal
Yes
Is deal PE backed
Yes
Total Acquired
100%
Secondary Transaction2023-09-01Canceled
Investor Sponsors -- | Stake Tags Majority |
Deal Amount Undisclosed | Is PE deal No |
Target Company Valuation -- | Is deal PE backed Yes |
Techniques Secondary Sale, Management Buy-out (MBO) | Total Acquired 65% |
Investor Sponsors
--
Deal Amount
Undisclosed
Target Company Valuation
NaN
Techniques
Secondary Sale, Management Buy-out (MBO)
Stake Tags
Majority
Is PE deal
No
Is deal PE backed
Yes
Total Acquired
65%
Funding
About
About
1st Phorm International LLC, founded in 2009 by Andy Frisella and Chris Klein, is headquartered in Fenton, Missouri. The company is a nutrition and supplement entity that develops and markets a wide range of health and fitness products. 1st Phorm focuses on providing high-performance nutrition solutions, emphasizing quality manufacturing and long-term results for its customers. Business/Product Breakdown: The company specializes in the production of dietary supplements, most notably its Phormula-1 line of whey protein isolates. These products are engineered for rapid digestion and muscle recovery, offering various formulations including standard, natural (no artificial sweeteners), and "clear" versions for a lighter digestive profile. Beyond protein powders, the brand maintains a comprehensive catalog of performance-driven nutrition products designed to support physical fitness goals and overall wellness.
Keywords
Keywords
Classified
Private